Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 20, 2020 | CR-CP Life Science Fund : Leads BELKIN Laser's US$12.25 Million Financing to Support the Disruptive, One-Second Glaucoma Laser Treatment | HONG KONG, July 20, 2020 /PRNewswire/ -- BELKIN Laser, the Israel-based start-up offering a 1-second, non-invasive glaucoma laser treatment, announces a round B financing with an oversubscription totaling US$12.25 million. The funding was l... |
Reviews 0
FAQ about Glaucoma Treatment
When was Glaucoma Treatment founded?
Glaucoma Treatment was founded in 2016.
What has the press written about Glaucoma Treatment?
Parsers VC has collected 2 articles mentioning Glaucoma Treatment, among them “CR-CP Life Science Fund : Leads BELKIN Laser's US$12.25 Million Financing to Support the Disruptive, One-Second Glaucoma Laser Treatment” (Jul 20, 2020).
Is Glaucoma Treatment still active?
Yes, Glaucoma Treatment is active; its latest activity on Parsers VC dates from Nov 11, 2021.